Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edus H Warren

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Frontiers in Immunology|September 26, 2022
Case report: A persistently expanded T cell response in an exceptional responder to radiation and atezolizumab for metastatic non-small cell lung cancerDavid G Coffey, Yuexin Xu, Andrea M H Towlerton, et al.
Blood Advances|November 17, 2022
Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHLSolomon A Graf, Ryan C Lynch, Chaitra S Ujjani, et al.
Blood|January 26, 2011
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteriaMary E D Flowers, Yoshihiro Inamoto, Paul A Carpenter, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
T-cells specific for KSHV and HIV migrate to Kaposi sarcoma tumors and persist over timeShashidhar Ravishankar, Andrea M H Towlerton, Iyabode L Tiamiyu, et al.
British Journal of Haematology|February 12, 2022
The impact of B-cell-directed therapy on SARS-CoV-2 vaccine efficacy in chronic lymphocytic leukaemiaChaitra Ujjani, Mazyar Shadman, Ryan C Lynch, et al.
Journal for Immunotherapy of Cancer|October 16, 2014
Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cellsSeth M Pollack, Robin L Jones, Erik A Farrar, et al.
Nature Genetics|November 26, 2009
Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host diseaseSteven A McCarroll, James E Bradner, Hannu Turpeinen, et al.
Blood|June 7, 2013
Toward eliminating HLA class I expression to generate universal cells from allogeneic donorsHiroki Torikai, Andreas Reik, Frank Soldner, et al.
Blood|August 1, 2002
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndromeH Joachim Deeg, Barry Storer, John T Slattery, et al.
Blood Advances|December 15, 2022
Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomasRyan C Lynch, Christina Poh, Chaitra S Ujjani, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Frontiers in Immunology|September 26, 2022
Case report: A persistently expanded T cell response in an exceptional responder to radiation and atezolizumab for metastatic non-small cell lung cancerDavid G Coffey, Yuexin Xu, Andrea M H Towlerton, et al.
Blood Advances|November 17, 2022
Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHLSolomon A Graf, Ryan C Lynch, Chaitra S Ujjani, et al.
Blood|January 26, 2011
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteriaMary E D Flowers, Yoshihiro Inamoto, Paul A Carpenter, et al.
Biorxiv : the Preprint Server for Biology|February 19, 2024
T-cells specific for KSHV and HIV migrate to Kaposi sarcoma tumors and persist over timeShashidhar Ravishankar, Andrea M H Towlerton, Iyabode L Tiamiyu, et al.
British Journal of Haematology|February 12, 2022
The impact of B-cell-directed therapy on SARS-CoV-2 vaccine efficacy in chronic lymphocytic leukaemiaChaitra Ujjani, Mazyar Shadman, Ryan C Lynch, et al.
Journal for Immunotherapy of Cancer|October 16, 2014
Tetramer guided, cell sorter assisted production of clinical grade autologous NY-ESO-1 specific CD8(+) T cellsSeth M Pollack, Robin L Jones, Erik A Farrar, et al.
Nature Genetics|November 26, 2009
Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host diseaseSteven A McCarroll, James E Bradner, Hannu Turpeinen, et al.
Blood|June 7, 2013
Toward eliminating HLA class I expression to generate universal cells from allogeneic donorsHiroki Torikai, Andreas Reik, Frank Soldner, et al.
Blood|August 1, 2002
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndromeH Joachim Deeg, Barry Storer, John T Slattery, et al.
Blood Advances|December 15, 2022
Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomasRyan C Lynch, Christina Poh, Chaitra S Ujjani, et al.
Pageof 9